+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 85Years
All Genders
ID06865885

Improving LDL Cholesterol Levels Using Inclisiran in Adults 18 to 85 Years With Multiple Health Conditions and Complex Medication Regimens Facing Drug Interactions That Limit Statin Use

Led by University of California, San Diego · Updated on 2026-07-13

100

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the effect of adding inclisiran to the standard care for lowering LDL cholesterol in patients at high cardiovascular risk who have multiple health conditions and take five or more medications that interact with statins. These patients often have autoimmune diseases, liver disease, chronic kidney disease, diabetes, or have had organ transplants, and face challenges in optimizing statin therapy due to drug interactions. The study is a randomized, open-label trial focusing on improving LDL levels in this vulnerable group. Participants will be randomly assigned to one of two groups one receiving subcutaneous inclisiran injections plus their usual care, and the other continuing with their standard lipid-lowering therapy alone. Patients in the inclisiran group will receive three doses of 284 mg at baseline, 3 months, and 9 months. The control group will maintain their current therapy without changes. The study includes five visits over 12 months screening, baseline, 3 months, 9 months, and 12 months. During each visit, participants will have blood tests to measure LDL cholesterol and other markers, medical history and medication reviews, and complete surveys. The primary outcome is the change in LDL cholesterol after 12 months. The study tracks adherence to the treatment plan and lifestyle guidance. Safety and treatment effects will be monitored throughout the year-long study period.

CONDITIONS

Brief Title

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Research Team

P

Pam Taub, MD

A

Antoinette S Birs, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here